A clinician-reviewed comparison of the five FDA-approved wrinkle-relaxing neuromodulators: how Botox, Dysport, Daxxify, Jeuveau, and Xeomin differ on onset, duration, formulation, spread, FDA approvals, and cost, and how to choose.
Botox, Dysport, Daxxify, Jeuveau, and Xeomin are the five FDA-approved botulinum toxin type A neuromodulators, and all relax muscles to soften wrinkles. They differ mainly in onset, duration, formulation, and spread: Daxxify lasts longest, Dysport spreads more, Xeomin is protein-free, Jeuveau is cosmetic-only, and Botox has the longest track record.
Five botulinum toxin type A products dominate the wrinkle-relaxing market in the United States, and their marketing often makes them sound more different than they are. Under the brand names sit five closely related proteins that all work by the same core mechanism, yet each has its own onset, duration, formulation, spread pattern, and set of FDA approvals. This guide compares Botox, Dysport, Daxxify, Jeuveau, and Xeomin on the attributes that actually change your experience and result, then explains how to weigh them for your own goals.
*FDA status: All five are FDA-approved to temporarily improve moderate to severe glabellar (frown) lines. Botox holds the broadest set of cosmetic and therapeutic approvals; the others are cleared for fewer areas. Common uses such as the forehead on most brands, masseter slimming, a lip flip, and neck bands are off-label, meaning the product is used outside its FDA-cleared indication. Unit counts are not interchangeable between brands. This is educational content, not medical advice.*
Every product here is a botulinum toxin type A, a purified protein that temporarily blocks the nerve signal telling a muscle to contract. Relax the muscle and the overlying skin folds less, which softens dynamic wrinkles like frown lines, forehead lines, and crow's feet. Because the underlying mechanism is identical across all five, the meaningful differences sit in the details: how quickly each starts working, how long the effect lasts, how it is formulated, how far it tends to diffuse from each injection point, and what the FDA has actually cleared it to treat.
Attribute | Botox | Dysport | Daxxify | Jeuveau | Xeomin ;; Active ingredient | onabotulinumtoxinA | abobotulinumtoxinA | daxibotulinumtoxinA | prabotulinumtoxinA | incobotulinumtoxinA ;; Maker | AbbVie (Allergan) | Galderma | Revance | Evolus | Merz ;; FDA cosmetic approval | 2002 | 2009 | 2022 | 2019 | 2011 ;; Typical onset | 3 to 5 days | 2 to 3 days | 1 to 3 days | 2 to 3 days | 3 to 5 days ;; Typical duration | 3 to 4 months | 3 to 4 months | up to 6 months | 3 to 4 months | 3 to 4 months ;; Unit scale vs Botox | reference | about 2.5 to 3 units to 1 | its own dosing | about 1 to 1 | about 1 to 1 ;; Formulation | with complexing proteins | with complexing proteins | peptide-stabilized, no albumin | with complexing proteins | no complexing proteins ;; Distinctive trait | longest track record | wider spread | longest lasting | cosmetic-only, often lowest priced | protein-free
Read this table as a starting map, not a verdict. In everyday practice the gap between two skilled injections using different brands is usually small, while the gap between a skilled and an unskilled injection of the same brand can be large. The rest of this guide unpacks what each column means for your decision.
All five belong to the same drug class and share the same active molecule family: botulinum toxin type A. Injected in tiny, precisely placed amounts, each one binds at the neuromuscular junction and blocks the release of acetylcholine, the chemical messenger that tells a muscle to fire. The treated muscle relaxes over several days, the skin above it creases less, and the effect gradually wears off as nerve signaling recovers, which is why every product in the class requires repeat treatment.
They also share a clinical profile that is far more alike than different. Head-to-head studies of glabellar and upper-face lines have generally found no significant difference in efficacy between these toxins when appropriately dosed, and their safety and side-effect patterns overlap heavily. All are prescription-only, must be given by or under a qualified medical professional, and are supplied as a powder that the injector reconstitutes before treatment. None is a filler: they relax movement rather than add volume, so none of them corrects hollowing or static folds that persist when your face is at rest. In short, the shared ground is large, and the differences below are refinements on a common foundation.
Onset is the first practical difference. Dysport and Jeuveau tend to show early effect within about 2 to 3 days, Daxxify can begin within 1 to 3 days, and Botox and Xeomin more typically take 3 to 5 days, with all five reaching full effect around two weeks. If you are treating before an event, faster onset can matter at the margin, though it does not change the final result.
Duration is where the clearest gap sits. Botox, Dysport, Jeuveau, and Xeomin all last roughly 3 to 4 months for most people, which is why the common question of whether Dysport or Jeuveau lasts longer usually has no meaningful answer: they are broadly comparable. Daxxify is the outlier, engineered with a stabilizing peptide to last noticeably longer, often around 6 months, which can mean fewer visits per year.
Formulation explains the remaining differences. Xeomin is stripped of the complexing proteins that surround the toxin in the other products, which is why it is nicknamed the naked toxin and is sometimes chosen for people worried about developing resistance over time. Daxxify swaps human albumin for a peptide stabilizer. Dysport is formulated with smaller molecules and tends to diffuse across a slightly wider field, which many injectors like for broad zones such as the forehead and is a common reason people say they prefer it. That wider spread also demands careful placement near delicate areas.
People often ask about the four FDA-approved neuromodulators, a phrasing that predates Daxxify. As of its 2022 approval there are five FDA-approved botulinum toxin type A products for aesthetics, and all five share one common cosmetic clearance: the temporary improvement of moderate to severe glabellar (frown) lines. That single shared indication is important, because much of what these products are used for cosmetically goes beyond it.
Botox carries the broadest label. It is FDA-approved for glabellar lines, lateral canthal lines (crow's feet), and forehead lines, plus a long list of therapeutic uses including chronic migraine, cervical dystonia, excessive underarm sweating, and overactive bladder. The others are cleared for fewer areas: Jeuveau is approved for glabellar lines only and is marketed as a cosmetic-only product, Xeomin has both a glabellar cosmetic approval and separate therapeutic ones, Dysport has glabellar cosmetic plus therapeutic approvals, and Daxxify is approved for glabellar lines and cervical dystonia. Popular treatments like masseter slimming, a lip flip, chin dimpling, and neck bands are off-label for every brand, which is legal and common but should be disclosed by your injector. As for why Jeuveau was banned: it was never pulled for safety. A 2020 trade-secret dispute led to a temporary import restriction that was resolved through a legal settlement, and the product remains FDA-approved and available.
No single product is right for everyone, but a few patterns help. If you want the option with the longest clinical history and the widest range of approved uses, Botox is the default reference point and a reasonable first choice, especially if you also have a medical indication such as migraine or jaw clenching. If you are treating a broad area like the forehead and like the idea of a smoother, more even diffusion, Dysport's wider spread is a common reason injectors reach for it.
If you want to stretch the time between appointments, Daxxify's longer duration is its main selling point, though it is newer and often priced at a premium. If you are a frequent, long-term user and want a formulation without complexing proteins, some clinicians favor Xeomin on the theory that a purer product may reduce the chance of the body forming resistance, although evidence for real-world resistance at cosmetic doses is limited. If your goal is straightforward glabellar treatment on a tighter budget, Jeuveau is often the lowest-priced option because it is positioned as cosmetic-only. Your medical history, the specific muscle being treated, and how your face responded to any prior toxin all weigh into the choice, which is a conversation to have with your injector rather than a decision to lock in from a table.
The safety profile is similar across all five because they share a mechanism. The most common side effects are mild and temporary: pinpoint bruising, redness, or swelling at injection sites, and short-lived headache. The effects that people worry about, such as a drooping eyelid or brow, an uneven or heavy look, or an unnatural frozen appearance, are usually the result of product migrating to a muscle it was not meant to reach or of dosing and placement, not of the brand itself. These typically resolve as the product wears off over weeks to a few months.
Every botulinum toxin, including all five here, carries the same FDA boxed warning that the toxin can, rarely, spread beyond the injection area and cause symptoms such as trouble swallowing or breathing. At the small doses used cosmetically this is very uncommon, but it is why treatment belongs with a qualified medical professional and why you should report any breathing, swallowing, or vision changes promptly. On the frequently asked question of what happens after 10 or 20 years of use: long-term cosmetic users generally look naturally aged rather than harmed, and there is no evidence of cumulative damage at aesthetic doses. Because the muscles are relaxed repeatedly, some users form fewer deep dynamic lines over time, an effect that applies equally across the class.
Price is one of the most misunderstood parts of choosing a neuromodulator, and honest comparison requires understanding units. We do not quote fixed prices here because they vary widely by provider, region, the number of units you need, and the specific brand, and any single figure would be misleading. Instead, focus on how the products are dosed, because that is what drives the real cost.
Botox, Xeomin, and Jeuveau are dosed on a roughly one-to-one scale, so their per-unit prices can be compared fairly directly. Jeuveau is frequently the least expensive per unit because it competes as a cosmetic-only entrant. Dysport is the common source of confusion: its per-unit price looks much lower, but it is not measured on the same scale, and it takes roughly 2.5 to 3 Dysport units to equal 1 Botox unit. Compared by treated area or by result, Dysport usually costs about the same as Botox, so a per-unit deal can be marketing framing rather than a genuine saving. Daxxify uses its own dosing and is often priced at a premium, though its longer duration can mean fewer sessions per year, which changes the annual math. The practical takeaway is to ask for the price per treated area, not just the price per unit, and to confirm which product and how many units are included.
When people ask which neuromodulator is best, the honest answer is that there is no universal winner. All five are comparable botulinum toxin type A products with overlapping results and safety. The right one depends on your priorities: longest duration points to Daxxify, broad even coverage to Dysport, a protein-free formulation to Xeomin, budget-conscious frown-line treatment to Jeuveau, and the deepest track record with the most approved uses to Botox. For most people, more than one of these would produce an excellent, natural-looking result.
That is why the choice of injector matters more than the choice of brand. Dosing, injection points, depth, and an eye for facial balance are what separate a natural result from an over-treated or asymmetric one, and a skilled clinician will often recommend a specific product for your anatomy and goals rather than the other way around. Bring your history and your priorities, ask which areas are on-label versus off-label for the product suggested, and expect a plan built around your face rather than a one-size-fits-all pitch. The best next step is not to pick a brand from an ad but to sit down with a qualified, licensed injector who can match the product to you.
In practice they are comparable. Both Dysport and Jeuveau typically last about 3 to 4 months for most people, so neither reliably outlasts the other. If longer duration is your main goal, Daxxify is the product designed to last longer, often around 6 months.
Jeuveau was never banned for safety and remains FDA-approved. A 2020 trade-secret lawsuit led to a temporary import restriction, which was resolved through a legal settlement. The dispute was commercial, not clinical, and the product continues to be sold in the United States.
Korea uses botulinum toxin widely, including local brands such as Botulax and Nabota (Nabota is sold as Jeuveau in the US). The popular Korean trend usually refers to skin boosters like polynucleotides used alongside toxin for glass-skin quality, not as a replacement for muscle-relaxing toxin.
Long-term users generally look naturally aged rather than damaged, with no evidence of harm at cosmetic doses. Because treated muscles are relaxed repeatedly, some people form fewer deep dynamic lines over time. This pattern applies across all five neuromodulators, since they share the same mechanism.